UK clears Janssen-Cilag’s drug for Crohn’s disease, ulcerative colitis
HQ Team May 19, 2025: The UK’s Medicines and Healthcare products Regulatory Agency has approved Janssen-Cilag Limited’s guselkumab (Tremfya) to treat Crohn’s disease.
Drugs
Health
Pharma